How are clotting disorders managed during pregnancy? 

The management of clotting disorders during pregnancy is a specialized area of care focused on protecting the health of the mother and the development of the placenta. Because pregnancy naturally increases the blood’s tendency to clot, individuals with an underlying thrombophilia require a proactive and structured medical plan to maintain a safe circulatory balance. In the UK, this process is led by a multidisciplinary team that monitors blood flow and provides preventative treatments to reduce the risk of venous thromboembolism or pregnancy complications. By following established clinical pathways, healthcare providers ensure that the increased physiological demands of pregnancy are met with the appropriate level of protection. 

What We’ll Discuss in This Article 

• The role of the multidisciplinary team in obstetric care 

• Why low-molecular-weight heparin is the standard treatment 

• The use of low-dose aspirin for placental support 

• Monitoring foetal growth and placental blood flow 

• Creating a safe plan for labour and delivery 

• Managing the high-risk postpartum recovery period 

The Multidisciplinary Approach to Care 

In the United Kingdom, a pregnancy complicated by a clotting disorder is managed through a “joint clinic” or a multidisciplinary team (MDT). This team typically includes a consultant obstetrician, a specialist midwife, and a haematologist who work together to create a personalized care plan. This collaborative approach ensures that the mother’s haematological needs are balanced with the obstetric requirements of the pregnancy. Regular appointments allow the team to adjust the management plan as the pregnancy progresses and the body’s clotting potential naturally rises. 

Pharmacological Prevention with Heparin 

Low-molecular-weight heparin (LMWH) is the primary medication used to manage clotting risks during pregnancy. Unlike some other anticoagulants, heparin does not cross the placenta, meaning it provides protection for the mother without affecting the developing baby. It is typically administered as a daily subcutaneous injection into the abdomen or thigh. The NHS recommends that women at high risk of blood clots receive a preventative dose of heparin throughout their pregnancy and for at least six weeks after birth. The dosage is calculated based on the mother’s weight and her specific type of clotting disorder. 

Supporting the Placenta with Aspirin 

For certain clotting disorders, particularly Antiphospholipid Syndrome (APS), low-dose aspirin is often prescribed alongside heparin. While heparin prevents large clots in the veins, aspirin acts as an antiplatelet to prevent microscopic clots from forming in the small blood vessels of the placenta. This support is vital for preventing complications such as pre-eclampsia or intrauterine growth restriction (IUGR). NICE guidelines advise that women with a high risk of pre-eclampsia should take 75mg to 150mg of aspirin daily from the 12th week of pregnancy until the baby is born. 

Monitoring Foetal Growth and Wellbeing 

When a clotting disorder is present, the medical team pays close attention to the function of the placenta and the growth of the baby. This usually involves more frequent ultrasound scans than a standard pregnancy. These scans often include “Doppler” assessments, which measure the resistance and speed of blood flow through the umbilical cord. If the Doppler readings show that the placenta is struggling to provide enough nutrients or oxygen, the team can intervene early to ensure the baby remains healthy. Regular blood pressure checks and urine tests are also performed to screen for early signs of pre-eclampsia. 

Planning for Labour and Delivery 

The management of blood thinners must be carefully timed around the onset of labour to ensure that the mother can safely receive pain relief, such as an epidural, and to minimize the risk of excessive bleeding during delivery. For many women, heparin injections are paused for a brief window usually 12 to 24 hours before a planned induction or caesarean section. If labour starts naturally, the patient is advised to stop their injections immediately and contact their maternity unit. The anaesthetic team will review the timing of the last dose before deciding if an epidural can be safely administered. 

Postpartum Care and Recovery 

The six weeks following childbirth, known as the puerperium, is the period of highest risk for a blood clot. During delivery, there is significant tissue trauma, and the body’s clotting system is at its absolute peak to prevent haemorrhage. To counteract this risk, preventative treatment with heparin is usually restarted within a few hours of delivery and continued for several weeks. New parents are encouraged to stay mobile, remain hydrated, and wear compression stockings if advised. This final stage of management ensures a safe transition as the body’s clotting proteins gradually return to their non-pregnant levels. 

Conclusion 

Managing clotting disorders during pregnancy relies on a combination of specialist monitoring and evidence-based medications like heparin and aspirin. The primary focus is on protecting the mother from venous clots while supporting the placenta to ensure healthy foetal development. Through a coordinated multidisciplinary approach, the UK healthcare system provides a structured environment for a safe and successful pregnancy. If you experience severe, sudden, or worsening symptoms, call 999 immediately. 

Authority Snapshot (E-E-A-T) 

This article outlines the clinical management of clotting disorders in pregnancy in accordance with UK health standards and safety protocols. The content is reviewed by Dr. Stefan Petrov, a UK-trained physician with experience in general medicine and acute care settings where the management of high-risk obstetric patients is a focus. All information is strictly aligned with the clinical guidelines and risk assessment pathways provided by the NHS and NICE.